Advertisement

Immunologic approaches to the classification of non-Hodgkin’s lymphomas

  • Thomas M. Grogan
  • Catherine M. Spier
  • Lynne C. Richter
  • Catherine S. Rangel
Part of the Cancer Treatment and Research book series (CTAR, volume 38)

Abstract

This chapter employs the working formulation (WF) of the non-Hodgkin’s lymphomas as a histologic base, because its ten morphologic categorizations are well defined and of established clinical utility, identifying prognostic gradations relevant to therapy [1]. Using this firm histologic base, the immunologic characteristics within each category are emphasized. As this chapter repeatedly demonstrates, many immunologic subtypes exist within certain WF categories, and these cannot always be predicted by morphologic classification [2]. Figure 1A details the WF categorizations relevant to the previously widely used Rappaport classification [3]. Figure 1B details some closely related entities to be discussed. Some of these represent lymphoma-related diseases, others represent newer categorizations derived from immunologic studies (e.g., peripheral T-cell lymphoma).

Keywords

Follicular Lymphoma Malignant Lymphoma Acquire Immune Deficiency Syndrome Mycosis Fungoides Hairy Cell Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rosenberg SA, Berard CW, Brown BW: National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphoma: Summary and description of a working formulation for clinical usage. Cancer 49:2112–2135, 1982.Google Scholar
  2. 2.
    Jaffe ES, Strauchen JA, Berard CW: Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin’s lymphomas. Am J Clin Pathol 77:46–49, 1982.PubMedGoogle Scholar
  3. 3.
    Rappaport H: Tumors of the hematopoietic system. In: Atlas of Tumor Pathology. Fascicle 8, Washington, DC: Armed Forces Institute of Pathology, 1966.Google Scholar
  4. 4.
    Mann RB, Jaffe ES, Berard CW: Malignant lymphomas: A conceptual understanding of morphologic diversity. Am J Pathol 94:105–175, 1979.PubMedGoogle Scholar
  5. 5.
    Nadler LM, Ritz J, Griffin JD, et al: Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. Prog Hematol 12:187–225, 1981.PubMedGoogle Scholar
  6. 6.
    Foon KA, Todd RF: Immunologic classification of leukemia and lymphoma. Blood 68:1–31, 1986.PubMedGoogle Scholar
  7. 7.
    Warnke RA, Rouse RV: Limitations encountered in the application of tissue section immunodiagnosis to the study of lymphomas and related disorders. Human Pathol 16: 326–331, 1985.Google Scholar
  8. 8.
    Bernard A, Bovmsell L, Dausset J, Milstein C, Schlossman SF (eds): Leucocyte typing: Human leukocyte differentiation antigens detected by monoclonal antibodies. Berlin, Springer-Verlag, 1984, pp 740–751.Google Scholar
  9. 9.
    Spier CM, Grogan TM, Fielder K, Richter L, Rangel C: Immunophenotypic profiles in ‘well differentiated’ lymphoproliferative disorders, with emphasis on small lymphocytic lymphoma. Human Pathol, 17:1126–1136, 1986.Google Scholar
  10. 10.
    Schwarting R, Stein H, Wang CY: The monoclonal antibodies anti-S-HCL-1 and anti-S-HCL-3 allow the diagnosis of hairy cell leukemia. Blood 65:974, 1985.PubMedGoogle Scholar
  11. 11.
    Stein H, Bonk A, Tolksdorf G, Lennert K, Rodt H, Gerdes R: Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin’s lymphomas. J Histo-chem Cytochem 28:746–760, 1980.Google Scholar
  12. 12.
    Grogan TM, Rangel CS, Richter LC, Wirt DP, Villar HV: Further delineation of the immunoarchitecture of the human spleen. Lymphology 17:61–68, 1984.PubMedGoogle Scholar
  13. 13.
    Levy R, Warnke R, Dorfman RF, et al: The monoclonality of human B-cell lymphomas. J Exp Med 145:1014–1028, 1977.PubMedGoogle Scholar
  14. 14.
    Grogan TM, Fielder K, Rangel C, et al: Peripheral T-cell lymphoma: Aggressive disease with heterogeneous immunotypes. Am J Clin Pathol 83:279–288, 1985.PubMedGoogle Scholar
  15. 15.
    Weiss LM, Crabtree GS, Rouse RV, Warnke RA: Morphologic and immunologic characterization of 50 peripheral T-cell neoplasms. Am J Pathol 118:316–324, 1985.PubMedGoogle Scholar
  16. 16.
    Cossman J, Chused TM, Fisher RI, et al: Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 43:4486–4490, 1983.PubMedGoogle Scholar
  17. 17.
    Grogan TM, Payne CM, Payne TB, Spier C, Cromey DW, Rangel C, Richter L: Cutaneous myiasis: Immunohistologic and ultrastructural morphometric features of a human botfly lesion. Am J Dermatopathol, 9:232–239, 1987.PubMedGoogle Scholar
  18. 18.
    Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA: T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med 313:534–538, 1985.PubMedGoogle Scholar
  19. 19.
    Kansas GS, Wood GS, Fishwild DM, Engleman EE: Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-Leu 8. J Immunol 134: 2995–3002, 1985.PubMedGoogle Scholar
  20. 20.
    Abel EA, Wood GS, Hoppe RT, Warnke RA: Expression of Leu 8 antigen, a majority T-cell marker, is uncommon in mycosis fungoides. J Invest Derm 85:199–202, 1985.PubMedGoogle Scholar
  21. 21.
    Gatenby PA, Kansas GS, Xian CY, Evans RL, Engleman EG: Dissection of immuno-regulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J of Immunol 129:1997–2000, 1982.Google Scholar
  22. 22.
    Wood GS, Strickler JG, Deneau DG, Egbert B, Warnke RA: Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation. J Am Acad Dermatol, 15:444–458, 1986.PubMedGoogle Scholar
  23. 23.
    Warnke R, Levy R: Immunopathology of follicular lymphomas: A model of B-lymphocyte homing. N Engl J Med 298:481–486, 1978.PubMedGoogle Scholar
  24. 24.
    Warnke R, Levy R: Detection of T and B cell antigens with hybridoma monoclonal antibodies: A biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 28: 771–776, 1980.PubMedGoogle Scholar
  25. 25.
    Grogan TM, Jones SE: Atlas of the immunologic, pathologic and clinical aspects of the malignant lymphomas. Adria monograph series, Adria Laboratories, Columbus, Ohio, 1984.Google Scholar
  26. 26.
    Lokin MR, Herzenberg LA: Analysis of cell populations with a fluorescence-activated cell sorter. Ann NY Acad Sci 254:163–171, 1975.Google Scholar
  27. 27.
    Cossman J, Neckers LM, Jaffe ES: Monoclonality of B-cell lymphomas: Demonstration by a simple assay for immunoglobulin in RNA. Lab Invest 50:13A, 1984.Google Scholar
  28. 28.
    Casey TT, Posey DH, McCurley TL: OKT4 epitope deficiency in significant proportions of the black population. A cause for underestimation of helper/suppressor lymphocyte ratios. Arch Pathol Lab Med 110:702–704, 1986.PubMedGoogle Scholar
  29. 29.
    Grogan TM, Rangel CS, Wirt DP, Richter LC, Bever FN, Jolley CS, Villar HV, Jones SE: Immunotopography of splenic lymphoma of small cleaved B-cell type. Diagn Immunol 3:126–132, 1985.PubMedGoogle Scholar
  30. 30.
    Bindl JM, Warnke RA: Advantages of detecting monoclonal antibody binding in tissue sections with biotin and avidin reagents in Coplin® jars. Am J Clin Pathol 85:490–493, 1986.PubMedGoogle Scholar
  31. 31.
    Grogan T, Spier C, Wirt DP, Hicks MJ, Paguin M, Hutter J, Miller T, Rangel C, Richter L, Jones S: Immunologic complexity of lymphoblastic lymphoma. Diagn Immunol 4:81 – 88, 1986.PubMedGoogle Scholar
  32. 32.
    Durie BGM, Grogan TM: CALLA-positive myeloma: An aggressive subtype with poor survival. Blood 66:229–232, 1985.PubMedGoogle Scholar
  33. 33.
    Straus W: Peroxidase procedures, technical problems encountered during their application. J Histochem Cytochem 27:1349, 1979.PubMedGoogle Scholar
  34. 34.
    Kronland R, Grogan T, Spier C, Wirt D, Rangel C, Richter L, Durie B, Greenberg B, Miller T, Jones S: Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow. Hum Pathol 16:1247–1254, 1985.PubMedGoogle Scholar
  35. 35.
    Warnke RA, Bindl J, Doggett R: Methods for decreasing interstitial immunoglobulin in tissue slices and cryostat sections. Histochem J 15:637, 1983.PubMedGoogle Scholar
  36. 36.
    Wood GS, Warnke R: Suppression of endogenous avidin-binding activity in tissues and its relevence to biotin-avidin detection systems. J Histochem Cytochem 29:1196–1204, 1981.PubMedGoogle Scholar
  37. 37.
    Verdi CJ, Grogan TM, Proteil R, Richter L, Rangel C: Liver biopsy immunotyping to characterize lymphoid malignancies. Hepatology 6:6–13, 1986.PubMedGoogle Scholar
  38. 38.
    Warnke R, Miller R, Grogan T, et al: Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. N Engl J Med 303:293–300, 1980.PubMedGoogle Scholar
  39. 39.
    Barnett Foster DE, Dorrington KJ, Painter RH: Structure and function of immunoglobulin domains. VIII. An analysis of the structural requirements in human IgGl for binding to the Fc receptor of human monocytes. J Immunol 124:2186–2190, 1980.PubMedGoogle Scholar
  40. 40.
    Wang CY, Good RA, Ammirati P, et al: Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med 151:1539–1544, 1980.PubMedGoogle Scholar
  41. 41.
    Wood GS, Warner NL, Warnke RA: Anti-Leu 3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J Immunol 131:212, 1983.PubMedGoogle Scholar
  42. 42.
    Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763, 1984.PubMedGoogle Scholar
  43. 43.
    Wood GS, Garcia CF, Dorfman RF, Warnke RA: The immunohistology of follicle lysis in lymph node biopsies from homosexual men. Blood 66:1092–1097, 1985.PubMedGoogle Scholar
  44. 44.
    Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC: Human T lympho-trophic virus type III infection of human alveolar macrophages. Blood 68:281–284, 1986.PubMedGoogle Scholar
  45. 45.
    Wood GS, Burke JS, Horning S, et al: The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. Blood 62:464–472, 1983.PubMedGoogle Scholar
  46. 46.
    Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA: Lymphoblastic lymphoma: An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 67:474–478, 1986.PubMedGoogle Scholar
  47. 47.
    Roberts GT, Babawi SB, Sackey K, Splence D, Sheth KV, Aur RJ: Lineage ambiguity in acute leukemia. Cancer 58:1473–1478, 1986.PubMedGoogle Scholar
  48. 48.
    Garson JA, Beverly PC, Coakham HB, et al: Monoclonal antibodies against human T lymphocytes label Purkinje neurones of many species. Nature 298:375–377, 1982.PubMedGoogle Scholar
  49. 49.
    Rusthoven JJ, Robinson JB, Kolin A, Pinkerton PH: The natural killer cell-associated HNK-1 (Leu 7) antibody reacts with hypertrophic and malignant prostatic epithelium. Cancer, in press.Google Scholar
  50. 50.
    Patterson BJ, Robinson JB, Pinkerton PH: Hematopoietic cell surface markers on metastatic small cell carcinoma with monoclonal antibodies. Am J Clin Pathol 84:159–165, 1985.PubMedGoogle Scholar
  51. 51.
    Kawaguchi K, Koike M: Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing’s sarcoma in bone and soft tissue. Am J Clin Pathol 86:79–83, 1986.PubMedGoogle Scholar
  52. 52.
    Gazdar AF, Bunn PA, Minna JD, Baylin SB: Origin of human small cell lung cancer. Science 229:679, 1985.PubMedGoogle Scholar
  53. 53.
    Sheibani K, Battifora H, Burke JS, Rappaport H: Leu-M1 antigen in human neoplasms: An immunohistologic study of 400 cases. Am J Surg Pathol 10:227–236, 1986.PubMedGoogle Scholar
  54. 54.
    Metzgar RS, Borowitz MJ, Jones NH, Dowell BL: Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med 154:1249–1254, 1981.PubMedGoogle Scholar
  55. 55.
    Grogan TM, Verdi C: CALLA expression on bile canaliculi. N Engl J Med 312:993–994, 1985.PubMedGoogle Scholar
  56. 56.
    Young LS, Clark D, Sixbey JW, Rickinson AB: Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet 1:240–242, 1986.PubMedGoogle Scholar
  57. 57.
    Fingeroth JD, Weiss JJ, Tedder TF, Strominger JL, Bird PA, Fearon DT: Epstein-Barr virus receptor of human B lymphocytes in the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4514, 1984.PubMedGoogle Scholar
  58. 58.
    Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Corrant MA, Peterson V, Freese UK: Replication of Epstein-Barr virus within the epithelial cells of oral hairy’ leukoplakia, an AIDS-associated lesion. N Eng J Med 313:1564–70, 1985.Google Scholar
  59. 59.
    Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O’Hara CJ, Groopman JE, Cho E-S, Oleske JM, Wong-Staal F, Gallo RC: HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 227:177–181, 1985.PubMedGoogle Scholar
  60. 60.
    Grogan TM, Tubbs RR: A double blind comparative immunotypic study between two institutions phenotyping non-Hodgkins lymphomas. Am J Clin Pathol, 87:478–484, 1987.PubMedGoogle Scholar
  61. 61.
    Borowitz MJ, Newby S, Brynes RK, Cousar JB, Whitcomb CC, Crissman JD, Byrne GE, Collins RD: Multi-institution study of non-Hodgkin’s lymphomas using frozen section immunoperoxidase: The Southeastern Cancer study group experience. Blood 63:1147–1152, 1984.PubMedGoogle Scholar
  62. 62.
    Palutke M, Schnitzer B, Narang S, Hyder DM, Parks S, Tabaczka P, Patch J: Storage and transportation of lymphoid tissue for immunophenotyping. Am J Clin Pathol 85:494–497, 1986.PubMedGoogle Scholar
  63. 63.
    Sheibani K, Winberg CD, Van De Velde S, Williams J, Rappaport H: Evaluation of expression of lymphocyte antigens in tissues placed in transport media. Comparison with cryostat fresh frozen section technique. An immunologic study of 56 cases. Am J Clin Pathol 85:297–304, 1986.PubMedGoogle Scholar
  64. 64.
    Jones SE, Grozea PN, Miller TP, Van Slyck EJ, Balcerzak SP, Costanzi JJ, Morrison FS, Eyre HJ, Fabian CJ, Dabich L, Dixon DO, Hartsock RJ, Grogan TM, Kjeldsberg C, Schnitzer B: Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with Levamisole or with Levamisole plus BCG for malignant lymphoma: A Southwest Oncology group study. J Clin Oncol 3:1318–1324, 1985.PubMedGoogle Scholar
  65. 65.
    Metter GE, Nathwani BN, Burke JS, Winberg CD, Mann RB, Barcos M, Kjeldsberg CR, Whitcomb CC, Dixon DO, Miller TP, Jones SE: Morphological subclassification of follicular lymphoma: Variability of diagnoses among hematopathologists, a collaborative study between the repository center and pathology panel for lymphoma clinical studies. J Clin Oncol 3:25–38, 1985.PubMedGoogle Scholar
  66. 66.
    Pangalis GA, Nathwani BN, Rappaport H: Malignant lymphoma, well differentiated lymphocytic: Its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenstrom. Cancer 39:999–1010, 1977.PubMedGoogle Scholar
  67. 67.
    Aisenberg AC, Long JC: Lymphocyte surface characteristics in malignant lymphoma. Am J Med 58:300, 1976.Google Scholar
  68. 68.
    Burns BF, Warnke RA, Doggett RS, Rouse RV: Expression of a T-cell antigen (Leu 1) by B-cell lymphomas. Am J Pathol 113:165–171, 1983.PubMedGoogle Scholar
  69. 69.
    Knowles DM II, Halper JP, Azzo W, Wang CY: Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers. Cancer 52:1369–1377, 1983.PubMedGoogle Scholar
  70. 70.
    Cossman J, Neckers LM, Hsu S-M, Longo D, Jaffe ES: Low grade lymphomas. Expression of developmentally regulated B-cell antigens. Am J Pathol 115: 117–124, 1984.PubMedGoogle Scholar
  71. 71.
    Harris NL, Bhan AK: Distribution of T-cell subsets of follicular and diffuse lymphomas of B-cell type. Am J Pathol 113:172–180, 1983.PubMedGoogle Scholar
  72. 72.
    Greenberg BR, Grogan TM, Takasug GJ, Trent JM, Hicks MJ, Durie BE: A unique malignant T-cell lymphoproliferative disorder with neutropenia simulating hairy cell leukemia. Cancer 56:2823–2830, 1985.PubMedGoogle Scholar
  73. 73.
    Colby TV, Warnke RA, Burke JS, Dorfman RF: Differentiation of chronic lymphocytic leukemia from Hodgkin’s disease using immunologic marker studies. Am J Surg Pathol 5:707–710, 1981.PubMedGoogle Scholar
  74. 74.
    Weisenburger DD, Nathwani BN, Diamond LW, Winberg CD, Rappaport H: Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases. Cancer 48:1415–1425, 1981.PubMedGoogle Scholar
  75. 75.
    Weisenburger DD, Kim H, Rappaport H: Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 49:1429–1438, 1982.PubMedGoogle Scholar
  76. 76.
    Palutke M, Eisenberg L, Mirchandani I, Tabaczka P, Husain M: Malignant lymphoma of small cleaved lymphocytes of the follicular mantle zone. Blood 59:317–322, 1982.PubMedGoogle Scholar
  77. 77.
    Weisenburger DD: Mantle-zone lymphoma. An immunohistologic study. Cancer 53:1073–1080, 1984.PubMedGoogle Scholar
  78. 78.
    Triozzi PL, Borowitz MJ, Gockerman JP: Gastrointestinal involvement and multiple lymphomatous polyposis in mantle-zone lymphoma. J Clin Oncol 4:866–873, 1986.PubMedGoogle Scholar
  79. 79.
    Harousseau JL, Flandrin G, Tricot G, Brouet JC, Seligmann M, Bernard J: Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter’s Syndrome: A study of 25 cases. Cancer 48:1302–1308, 1981.PubMedGoogle Scholar
  80. 80.
    Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Foerster J, Athens JW, Lukens JN: Clinical Hematology, 8th edition. Lea and Febiger, Philadelphia, 1981, Chapters 67 and 69.Google Scholar
  81. 81.
    Hicks MJ, Grogan TM, Fielder K, Spier CM: Differentiation of chronic lymphocytic leukemia from other well to intermediate differentiated’ lymphoproliferative disorders by the mouse rosette assay. Diag Immunol 4:31–36, 1986.Google Scholar
  82. 82.
    Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H: Non-Hodgkin’s lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer 31: 806–823, 1973.PubMedGoogle Scholar
  83. 83.
    Berard CW, Dorfman RF: Histopathology of malignant lymphomas. Clin Haematol 3:39–76, 1974.Google Scholar
  84. 84.
    Nathwani BH, Winberg CD, Diamond LW, Bearman RM, Kim H: Morphologic criteria for the differentiation of follicular lymphoma from florid reactive follicular hyperplasia: A study of 80 cases. Cancer 48:1794–1806, 1981.PubMedGoogle Scholar
  85. 85.
    Jaffe ES, Shevach EM, Frank MM, Berard CW, Green I: Nodular lymphoma — evidence for origin from follicular B lymphocytes. N Engl J Med 290:813–819, 1974.PubMedGoogle Scholar
  86. 86.
    Stein H, Berdes J, Mason DY: The normal and malignant germinal centre. Clin Haematol 11:531–559, 1982.PubMedGoogle Scholar
  87. 87.
    Tubbs RR, Fishleder A, Weiss RA, Savage RA, Sebek BA, Weick JK: Immunohistologic cellular phenotypes of lymphoproliferative disorders: Comprehensive evaluation of 564 cases including 257 non-Hodgkin’s lymphomas classified by the International Working Formulation. Am J Pathol 113:207–221, 1983.PubMedGoogle Scholar
  88. 88.
    Grogan TM, Hicks MJ, Jolley CS, Rangel CS, Jones SE: Identification of two major B cell forms of nodular mixed lymphoma. Lab Invest 51:504–514, 1984.PubMedGoogle Scholar
  89. 89.
    Harris NL, Nadler LM, Bhan AK: Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities. Am J Pathol 117:262–272, 1984.PubMedGoogle Scholar
  90. 90.
    Gerdes J, Dallenbach F, Lennert K: Growth fractions in malignant non-Hodgkin’s lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncology 2:365–371, 1984.Google Scholar
  91. 91.
    Rudders RA, Ahl ET, Delellis RA, Bernstein S, Begg CB: Surface marker identification of small cleaved follicular center cell lymphoma with a highly favorable prognosis. Cancer Res 42:349–353, 1982.PubMedGoogle Scholar
  92. 92.
    Harris NL, Bahn A: Immunoglobulin in lymphomas and reactive lymph nodes. Human Pathol 13:610–617, 1982.Google Scholar
  93. 93.
    Garcia CF, Weiss LM, Warnke RA, Wood GA: Cutaneous follicular lymphoma. Am J Surg Pathol 10:454–463, 1986.PubMedGoogle Scholar
  94. 94.
    Naiem M, Gerdes J, Abdulaziz Z, Stein H, Mason DY: Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohisto-logical analysis of lymphoid tissue. J Clin Pathol 36:167–175, 1983.PubMedGoogle Scholar
  95. 95.
    Dvoretsky P, Wood GS, Levy R, Warnke RA: T-lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils. Human Pathol 13:618–625, 1982.Google Scholar
  96. 96.
    Braziel RM, Sussman E, Jaffe ES, Neckers LM, Cossman J: Induction of immunoglobulin secretion in follicular non-Hodgkins lymphomas: Role of immunoregulatory T cells. Blood 66:128–134, 1985.PubMedGoogle Scholar
  97. 97.
    Ford RJ, Kouttab NM, Shasrabuddhe CG, Davis FM, Mehta SR: Growth factor mediated proliferation in B cell non-Hodgkin’s lymphomas. Blood 65:1335–1341, 1985.PubMedGoogle Scholar
  98. 98.
    Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J of Immunol 133:1710–1715, 1984.Google Scholar
  99. 99.
    Aisenberg AC, Wilkes PM, Harris NL: Monoclonal antibody studies in non-Hodgkin’s lymphoma. Blood 61:469, 1983.PubMedGoogle Scholar
  100. 100.
    Aisenberg AC, Wilkes BM, Long JC, Harris NL: Cell surface phenotype in lymphopro-liferative disease. Am J Med 68:206, 1980.PubMedGoogle Scholar
  101. 101.
    Gregg EO, Al-Saffar N, Jones BB, Wright DH, Stevenson FU, Smith JL: Immunoglobulin negative follicle centre cell lymphoma. Br J Cancer 50:735–744, 1984.PubMedGoogle Scholar
  102. 102.
    Gerdes J, Stein H: Complement (C3) receptors on dendritic reticulum cells of normal and malignant lymphoid tissue. Clin Exp Immunol 48:348, 1982.PubMedGoogle Scholar
  103. 103.
    Stashenko P, Nadler LM, Hardy R, Schlossman SF: Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci USA 78:3848, 1981.PubMedGoogle Scholar
  104. 104.
    Iida K, Nadler LM, Nussenzweig V: Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med 158:1021–1033, 1983.PubMedGoogle Scholar
  105. 105.
    Kim H, Dorfman RF, Rappaport H: Signet ring cell lymphoma: A rare morphological and functional expression of nodular (follicular) lymphoma. Am J Surg Pathol 2:119–132, 1978.PubMedGoogle Scholar
  106. 106.
    Frizzera G, Anaya JS, Banks PM: Neoplastic plasma cells in follicular lymphomas. Clinical and pathologic findings in six cases. Virchows Arch (Pathol Anat) 409:149–162, 1986.Google Scholar
  107. 107.
    Grogan TM, Payne CM, Richter LC, Rangel CS: Signet-ring cell lymphoma of T-cell origin. An immunocytochemical and ultrastructural study relating giant vacuole formation to cytoplasmic sequestration of surface membrane. Am J Surg Path 9:684–692, 1985.PubMedGoogle Scholar
  108. 108.
    Weiss L, Wood G, Dorfman R: T-cell signet-ring cell lymphoma. Am J Surg Pathol 9:273–280, 1985.PubMedGoogle Scholar
  109. 109.
    Rappaport H, Winter WJ, Hicks EB: Follicular lymphoma: A re-evaluation of its position in the schem of malignant lymphoma, based on a survey of 253 cases. Cancer 9:792–821, 1956.PubMedGoogle Scholar
  110. 110.
    Erickson DJ, Cousar JB, Flexner JM, Collins RD: Transformation of follicular center cell (FCC) lymphomas (Lukes-Collins classification): Progression of small cleaved cell (SCC) type to transformed cell type. Lab Invest 44:16A, 1981.Google Scholar
  111. 111.
    Come SE, Jaffe ES, Anderson JC: Non-Hodgkins lymphomas in leukemic phase: Clinico-pathologic correlations. Am J Med 69:667–674, 1980.PubMedGoogle Scholar
  112. 112.
    Weiss LM, Warnke RA: Follicular lymphoma with blastic conversion: A report of two cases with confirmation by immunoperoxidase studies on bone marrow sections. Am J Clin Pathol 83:681–686, 1985.PubMedGoogle Scholar
  113. 113.
    Mann RB, Jaffe ES, Braylon RC, Nanba K, Frank MM, Ziegler JL, Berard CW: Non-endemic Burkitt’s lymphoma: A B cell tumor related to germinal centers. N Engl J Med 295:685–691, 1976.PubMedGoogle Scholar
  114. 114.
    Mintzer DM, Andreeff M, Filippa DA, Jhanwar SC, Chaganti RSK, Koziner B: Progression of nodular poorly differentiated lymphocytic lymphoma to Burkitt’s-like lymphoma. Blood 64:415–421, 1984.PubMedGoogle Scholar
  115. 115.
    Gay R, Fielder K, Grogan T: Quinidine-induced reactive lymph adenopathy. Am J Med 82:143–145, 1987.PubMedGoogle Scholar
  116. 116.
    Wirt DP, Grogan TM Jolley CS, Rangel CS, Payne CM, Hansen RC, Lynch PJ, Schuchardt M: The immunoarchitecture of cutaneous pseudolymphoma. Human Pathol 6:492–510, 1985.Google Scholar
  117. 117.
    Levy N, Nelson J, Meyer P, Lukes RJ, Parker JW: Reactive lymphoid hyperplasia with single class (monoclonal) surface immunoglobulin. Am J Clin Pathol 80:300–308, 1983.PubMedGoogle Scholar
  118. 118.
    Sklar J, Cleary ML, Thielemans K, Gralow J, Warnke R, Levy R: Bicional B-cell lymphoma. N Engl S Med 311:20–27, 1984.Google Scholar
  119. 119.
    Schwartz JE, Grogan TM, Hicks MJ, Weinrach RS, Miller TP: Pseudonodular T-cell lymphoblastic lymphoma. Am J Med 77:947–949, 1984.PubMedGoogle Scholar
  120. 120.
    Timens W, Visser L, Poppema S: Nodular lymphocyte predominance type of Hodgkin’s disease is a germinal center lymphoma. Lab Invest 54:457–461, 1986.PubMedGoogle Scholar
  121. 121.
    Hansmann M-L, Wacker H-H, Radzun HJ: Paragranuloma is a variant of Hodgkin’s disease with a predominance of B-cells. Virchows Arch (Pathol Anat) 409:171–181, 1986.Google Scholar
  122. 122.
    Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT Jr: Malignant lymphoma. I. The histology and staging of 473 patients at the National Cancer Institute. Cancer 50:2699–2707, 1982.PubMedGoogle Scholar
  123. 123.
    Foucar K, Armitage JO, Dick FR: Malignant lymphoma, diffuse mixed small and large cell. A clinicopathologic study of 47 cases. Cancer 51:2090–2099, 1983.PubMedGoogle Scholar
  124. 124.
    Kim H, Jacobs C, Warnke RA, Dorfman RF: Malignant lymphoma with a high content of epithelioid histiocytes. A distinct clinicopathologic entity and a form of so-called Lennert’s lymphoma. Cancer 41:620–635, 1978.PubMedGoogle Scholar
  125. 125.
    Lennert K, Mestdagh J: Lymphogranulomatosen mit konstant hohem epitheloid-zellgehalt. Virchows Arch (Pathol Anat) 344:1–20, 1968.Google Scholar
  126. 126.
    Garvin AJ, Simon RM, Osborne CK, Merrill J, Young RC, Berard CW: An autopsy study of histologic progression in non-Hodgkin’s lymphomas. 192 cases from the National Cancer Institute. Cancer 52:393–398, 1983.PubMedGoogle Scholar
  127. 127.
    Rappaport H, Pangalis GA, Nathwani BN: The evolution of immunoblastic lymphomas in morphologically non-neoplastic immunoproliferative diseases. Rev Cancer 29:1502–1512, 1972.Google Scholar
  128. 128.
    Leonhard SA, Muhleman AF, Hurtubise PE, Martelo OJ: Emergence of Immunoblastic sarcoma in Waldenstrom’s macroglomulinemia. Cancer 45:3102–3107, 1980.PubMedGoogle Scholar
  129. 129.
    Kradin RL, Young RH, Kradin LA, Mark EJ: Immunoblastic lymphoma arising in chronic lymphoid hyperplasia of the pulmonary interstitium. Cancer 50:1339–1343, 1982.PubMedGoogle Scholar
  130. 130.
    Bauer TW, Mendelsohn G, Humphrey RL, Mann RB: Angioimmunoblastic lymph-adenopathy progressing to immunoblastic lymphoma with prominent gastric involvement. An immunohistochemical study of two cases. Cancer 50:2089–2098, 1982.PubMedGoogle Scholar
  131. 131.
    Barcos MP, Lukes RJ: Malignant lymphoma of convoluted lymphocytes — a new entity of possible T-cell type. In: Sinks LF, Godden J, eds: Conflicts in Childhood Cancer. An Evaluation of Current Management, Vol. 4, New York, Alan R Liss, 1975, pp 147–148.Google Scholar
  132. 132.
    Nathwani BN, Kim H, Rappaport H: Malignant lymphoma, lymphoblastic. Cancer 38: 964–983, 1976.PubMedGoogle Scholar
  133. 133.
    Cossman J, Jaffe ES, Fisher RI: Immunologic phenotypes of diffuse, aggressive, non-Hodgkin’s lymphomas. Correlation with clinical features. Cancer 54:1310–1317, 1984.PubMedGoogle Scholar
  134. 134.
    Tubbs RR, Fishleder A, Weiss RA, Savage RA, Sebek BA, Weick JK: Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin’s lymphomas classified by the International Working Formulation. Am J Pathol 113:207–221, 1983.PubMedGoogle Scholar
  135. 135.
    Nathwani BN, Metter GE, Gams RA, Bartolucci AA, Hartsock RJ, Neiman RS, Byrne GE Jr, Barcos M, Kim H, Rappaport H: Malignant lymphoma, mixed cell type, diffuse. Blood 62:200–208, 1983.PubMedGoogle Scholar
  136. 136.
    Burke JS, Butler JJ: Malignant lymphoma with a high content of epithelioid histiocytes (Lennert’s lymphoma). Am J Clin Pathol 66:1–9, 1976.PubMedGoogle Scholar
  137. 137.
    Hayes D, Robertson JH: Malignant lymphoma with a high content of epithelioid histiocytes. J Clin Pathol 32:675–680, 1979.PubMedGoogle Scholar
  138. 138.
    Kim H, Nathwani BN, Rappaport H: So-called Lennert’s lymphoma. Is it a clinicopathologic entity? Cancer 45:1379–1399, 1980.PubMedGoogle Scholar
  139. 139.
    Palutke M, Varadachai C, Weise RW, Husain M, Tabacza P: Lennert’s lymphoma, a T-cell neoplasm. Am J Clin Pathol 69:643–646, 1978.Google Scholar
  140. 140.
    Han T, Barcos M, Yoon JM, Rakowski I, Minowada J: Malignant lymphoma with a high content of epithelioid histiocytes: Report of a T-cell variant of so-called Lennert lymphomas and review of the literature. Med Pediat Oncol 8:227–236, 1980.Google Scholar
  141. 141.
    Feller AC, Griesser GH, Mak TW, Lennert K: Lymphoepithelioid lymphoma (Lennert’s lymphoma) is a monoclonal proliferation of helper/inducer T cells. Blood 68:663–667, 1986.PubMedGoogle Scholar
  142. 142.
    Spier CM, Lippman SM, Miller TP, Grogan TM: Lennert’s lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival. Cancer, in press.Google Scholar
  143. 143.
    Doggett RS, Wood GS, Horning S, Levy R, Dorfman RF, Bindl J, Warnke RA: The immunological characterizations of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol 115:245–252, 1984.PubMedGoogle Scholar
  144. 144.
    Horning SJ, Doggett RS, Warnke RA, Dorfman RF, Cox RS, Levy R: Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. Blood 63:1209–1215, 1984.PubMedGoogle Scholar
  145. 145.
    Freedman AS, Boyd AW, Anderson KC, Fisher DC, Pinkus GS, Schlossman SF, Nadler LM: Immunologic heterogeneity of diffuse large cell lymphoma. Blood 65:630, 1985.PubMedGoogle Scholar
  146. 146.
    Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA: Histologic conversion in the non-Hodgkin’s lymphomas. J Clin Oncol 1:11–16, 1983.PubMedGoogle Scholar
  147. 147.
    Risdall R, Hoppe RT, Warnke R: Non-Hodgkin’s lymphoma. A study of the evolution of the disease based upon 92 autopsied cases. Cancer 44:529–542, 1979.PubMedGoogle Scholar
  148. 148.
    Levine AM, Taylor CR, Schneider DR, Koehler SC, Forman SJ, Lichtenstein A, Lukes RJ, Feinstein DI: Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features. Blood 58:52–61, 1981.PubMedGoogle Scholar
  149. 149.
    Maurer R, Taylor CR, Parker JW, Cramer A, Lukes RJ: Immunoblastic sarcoma: Morphologic criteria and the distinction of B and T cell types. Oncology 39:42–50, 1982.PubMedGoogle Scholar
  150. 150.
    Anderson KC, Bates MP, Slaghenhoupt B, Schlossman SF, Nadler LM: A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol 132:3172–3179, 1984.PubMedGoogle Scholar
  151. 151.
    Anderson KC, Park EK, Bates MP, et al: Antigens on human plasma cells identified by monoclonal antibodies. J Immunol 130:1132–1138, 1983.PubMedGoogle Scholar
  152. 152.
    Linden MD, Tubbs RR, Weick JK: Large cell lymphoma with diffuse sclerosis: A B cell neoplasm of late secretory pre-plasma cells. Cleve Clin Q.Google Scholar
  153. 153.
    Grogan TM, Spier CM, Miller T: Immunotyping malignant lymphomas: A boon to diagnosis. Cleve Clin Q 53:315–317, 1986.PubMedGoogle Scholar
  154. 154.
    Tamaki T, Katagiri S, Kanayama Y, Konishi I, Yonezawa T, Tarui S, Kitani T: Helper T-cell lymphoma with marked plasmacytosis and polyclonal hypergammaglobulinemia. Cancer 53:1590–1595, 1984.PubMedGoogle Scholar
  155. 155.
    Rosas-Uribe A, Rappaport H: Malignant lymphoma, histiocytic type with sclerosis (sclerosing reticulum cell sarcoma). Cancer 29:946–953, 1972.PubMedGoogle Scholar
  156. 156.
    Miller JB, Variakojis D, Bitran JD, Sweet DL, Kwizie JJ, Golomb HM, Ultmann JE: Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction. Cancer 47:748–756, 1981.PubMedGoogle Scholar
  157. 157.
    Trump DL, Mann RB: Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostic subset of patients with non-Hodgkin’s lymphoma. Cancer 50:277–282, 1982.PubMedGoogle Scholar
  158. 158.
    Waldron JA Jr, Newcomer LN, Katz ME, Cadman E: Sclerosing variants of follicular center cell lymphomas presenting in the retroperitoneum. Cancer 52:712–720, 1983.PubMedGoogle Scholar
  159. 159.
    Bennett MH: Sclerosis in non-Hodgkin’s lymphomata. Br J Cancer 31 (Suppl II): 44–52, 1975.Google Scholar
  160. 160.
    Ree HJ, Leone LA, Crowley JP: Sclerosis in diffuse histiocytic lymphoma: A clinicopathologic study of 25 cases. Cancer 49:1636–1648, 1982.PubMedGoogle Scholar
  161. 161.
    Pinkus GS, Said JW, Hargreaves H: Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobulated nuclei, with a report of four cases. Am J Clin Pathol 72:540–550, 1979.PubMedGoogle Scholar
  162. 162.
    Cerezo L: B-cell multilobulated lymphoma. Cancer 52:2277–2280, 1983.PubMedGoogle Scholar
  163. 163.
    Weiss RL, Kjeldsberg CR, Colby TV, Marty J: Multilobulated B cell lymphomas: A study of seven cases. J Hematol 3:79–86, 1985.Google Scholar
  164. 164.
    Kluin PM, Stootweg PJ, Schuurman JH, Go DM, Rademakers LH, van der Putte SC, van Unnik JA: Primary B-cell malignant lymphoma of the maxilla with a sarcomatous pattern and multilobualted nuclei. Cancer 54:1598–1605, 1984.PubMedGoogle Scholar
  165. 165.
    Jaffe ES: Malignant histiocytosis and true histiocytic lymphomas. In: Surgical Pathology of the Lymph Nodes and Related Organs. Jaffe ES, (ed): Philadelphia, WB Saunders, 1985, Chapter 15.Google Scholar
  166. 166.
    Mirchandani I, Shah I, Palutke M, Varadachai C, Tabaczka P, Franklin R, Bishop C: True histiocytic lymphoma. A report of four cases. Cancer 52:1911–1918, 1983.PubMedGoogle Scholar
  167. 167.
    Isaacson P, Wright DH, Jones DB: Malignant lymphoma of true histiocytic (monocyte/ macrophage) origin. Cancer 51:80–91, 1983.PubMedGoogle Scholar
  168. 168.
    Turner RR, Wood GS, Beckstead JH, Colby TV, Horning SJ, Warnke RA: Histiocytic malignancies: Morphologic, immunologic and enzymatic heterogeneity. Am J Surg Path 8:485–500, 1984.PubMedGoogle Scholar
  169. 169.
    Jaffe ES, Costa JC, Fauci A, Cossman J, Tsokos M: Malignant lymphoma and erythro-phagocytosis simulating malignant histiocytosis. Am J Med 75:741–749, 1983.PubMedGoogle Scholar
  170. 170.
    Whitcomb CC, Sternheim WL, Borowitz MJ, Davila E, Byrne GE Jr: T-cell lymphoma mimicking granulocytic sarcoma. Am J Clin Pathol 84:760–763, 1985.PubMedGoogle Scholar
  171. 171.
    Greer JP, Kinney MC, Cousar JB, Flexner JM, Dupont WD, Graber SE, Greco FA, Collins RD, Stein RS: Lymphocyte-depleted Hodgkin’s disease. Clinicopathologic review of 25 patients. Am J Med 81:208–214, 1986.PubMedGoogle Scholar
  172. 172.
    Kant JA, Hubbard SM, Longo DL, Simon RM, DeVita VT Jr, Jaffe ES: The pathologic and clinical heterogeneity of lymphocyte depleted Hodgkin’s disease. J Clin Oncol 4:284–294, 1986.PubMedGoogle Scholar
  173. 173.
    Miller TP, Bryne GE, Jones SE: Mistaken clinical and pathologic diagnosis of Hodgkin’s disease: A Southwest Oncology Group study. Cancer Treat Rep 66:645–652, 1982.PubMedGoogle Scholar
  174. 174.
    Strickler JG, Michie SA, Warnke RA, Dorfman RF: The syncytial variant of nodular sclerosing Hodgkin’s disease. Am J Surg Pathol 10:470–477, 1986.PubMedGoogle Scholar
  175. 175.
    Barcos MP, Lukes RJ: Malignant lymphomas of convoluted lymphocytes. A new entity of possible T cell type. In Sinks LF, Godden JO (eds): Conflicts in Childhood Cancer, vol 4, New York, Alan R Liss, 1975, p 147.Google Scholar
  176. 176.
    Nathwani BN, Kim B, Rappaport H: Malignant lymphoma, lymphoblastic. Cancer 38: 964–983, 1976.PubMedGoogle Scholar
  177. 177.
    Bernard A, Boumsell L, Reinberg EL, Nadler LM, Ritz J, Coppin H, Richard Y, Valens F, Dausset J, Flandrin G, Lemerle J, Schlossman SF: Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: Evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood 57:1105–1110, 1981.PubMedGoogle Scholar
  178. 178.
    Roper M, Crist WM, Metzgar R, Ragab AH, Smith S, Storling K, Pullen J, Leventhal B, Bartolucci AA, Cooper MD: Monoclonal antibody characterization of surface antigens in childhood T cell lymphoid malignancies. Blood 61:830, 1983.PubMedGoogle Scholar
  179. 179.
    Link M, Warnke R, Finlay J, Amylon M, Miller R, Dilley J, Levy R: A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Blood 62: 722–728, 1983.PubMedGoogle Scholar
  180. 180.
    Jaffe ES, Berard CW: Lymphoblastic lymphoma: A term rekindled with new precision. Ann Intern Med 89:415–417, 1978.PubMedGoogle Scholar
  181. 181.
    Reinherz EL, Kung P, Goldstein G, Levey RH, Schlossman SF: Discreet stages of human intrathymic differentiation. Analysis of normal thymocytes and leukemic lymphoblasts of T cell lineage. Proc Natl Acad Sci USA 77:1588, 1980.PubMedGoogle Scholar
  182. 182.
    Kjeldsberg CR, Wilson JF, Berard CW: Non-Hodgkin’s lymphoma in children. Human Pathol 14:612–627, 1983.Google Scholar
  183. 183.
    Bhan AK, Reinherz EL, Poppema S, McClusky RT, Schlossman SF: Location of T-cell and major histocompatibility antigens in the human thymus. J Exp Med 152:771–782, 1980.PubMedGoogle Scholar
  184. 184.
    Donion JA, Jaffe ES, Braylan RC: Terminal deoxynucleotidyl transferase activity in malignant lymphomas. N Engl J Med 297:461–464, 1977.Google Scholar
  185. 185.
    Habeshaw JA, Catley PF, Stansfield AG, Ganeshaguru K, Hoffbrand AV: Terminal deoxynucleotidyl transferase activity in lymphoma. Br J Cancer 39:566–569, 1979.PubMedGoogle Scholar
  186. 186.
    Kung PC, Long JC, McCaffrey RP, Ratliff RL, Harrison TA, Baltimore D: Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma. Am J Med 64:788–794, 1978.PubMedGoogle Scholar
  187. 187.
    Kurek AS, Davey FR: Terminal deoxynucleotidyl transferase. Human Pathol 12:867–869, 1981.Google Scholar
  188. 188.
    Long JC, McCaffrey RP, Aisenberg AC, Marks SM, Kung PC: Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma. Cancer 44:2127–2139, 1979.PubMedGoogle Scholar
  189. 189.
    Borowitz MJ, Croker BP, Metzgar RS: Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia. Am J Clin Pathol 79:387–391, 1983.PubMedGoogle Scholar
  190. 190.
    Ritz J, Nadler LM, Bhan AK, Notis-McConarty J, Pesandro JM, Schlossman SF: Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood 56:648–652, 1981.Google Scholar
  191. 191.
    Murphy S, Jaffe ES: Terminal transferase activity and lymphoblastic neoplasms (editorial). N Engl J Med 311:1373–1374, 1984.PubMedGoogle Scholar
  192. 192.
    Beckstead JH, Wood GS, Turner RR: Histiocytosis X cells and Langerhans cells: Enzyme histochemical and immunologic similarities. Hum Pathol 15:826, 1984.PubMedGoogle Scholar
  193. 193.
    Mokhtar N, Hsu SM, Rajnikant PL, Haynes BF, Jaffe ES: Thymoma: Lymphoid and epithelial components mirror the phenotype of normal thymus. Human Pathol 15:378–384, 1984.Google Scholar
  194. 194.
    Nagle RB, Clark VA, McDaniel KM, Davis JR: Immunohistochemical demonstration of keratins in human ovarian neoplasms. J Histochem Cytochem 31:1010–1014, 1983.PubMedGoogle Scholar
  195. 195.
    Nagle RB, McDaniel KM, Clark VA, Payne CM: The use of antikeratin antibodies in the diagnosis of human neoplasms. Am J Clin Pathol 79:458–467, 1983.PubMedGoogle Scholar
  196. 196.
    Berard C, O’Conor GT, Thomas LB, Torloni H: Histopathological definition of Burkitt’s tumor. Bull WHO 1969; 40:601–607, 1969.Google Scholar
  197. 197.
    Payne CM, Grogan TM, Croney DW, Ejore CG, Kerrigan DP: An ultrastructural morphometric and immunophenotypic evaluation of Burkitt’s and Burkitt’s-like lymphomas. Lab Invest 57:200–217, 1987.PubMedGoogle Scholar
  198. 198.
    O’Conor GT, Rappaport H, Smith E: Childhood lymphoma resembling ‘Burkitt’s tumor’ in the United States. Cancer 18:411–417, 1965.PubMedGoogle Scholar
  199. 199.
    Dorfman RF: Childhood lymphosarcoma in St. Louis, Missouri clinically and histologically resembling burkitt’s tumor. Cancer 18:418–430, 1965.PubMedGoogle Scholar
  200. 200.
    Levine PH, Cho BR, Connelly RR, et al: The American Burkitt’s Lymphoma Registry: A progress report. Ann Intern Med 83:31–36, 1975.PubMedGoogle Scholar
  201. 201.
    Cohen MH, Bennett JM, Berard CW, et al: Burkitt’s tumor in the United States. Cancer 23:1259–1272, 1969.PubMedGoogle Scholar
  202. 202.
    Miliauskas MB, Berard CW, Young RC, et al: Undifferentiated non-Hodgkin’s lymphomas (Burkitt’s and non-Burkitt’s types). The relevance of making this histologic distinction. Cancer 50:2115–2121, 1982.PubMedGoogle Scholar
  203. 203.
    Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS: Occurrence of non-Hodgkin’s lymphoma after therapy for Hodgkin’s disease. N Engl J Med 300:452–458, 1979.PubMedGoogle Scholar
  204. 204.
    Ziegler JL, Drew WL, Miner RC, et al: Outbreak of Burkitt’s-like lymphoma in homosexual men. Lancet 2:631–633, 1982.PubMedGoogle Scholar
  205. 205.
    Ziegler JL, Beckstead JA, Volberding PA, et al: Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565–570, 1984.PubMedGoogle Scholar
  206. 206.
    Mintzer DM, Andreeff M, Filippa DA, Jhanwar SC, Chaganti RSK, Koziner B: Progression of nodular poorly differentiated lymphocytic lymphoma to Burkitt’s-like lymphoma. Blood 64:415–421, 1984.PubMedGoogle Scholar
  207. 207.
    Weiss LM, Warnke RA: Follicular lymphoma with blastic conversion: A report of two cases with confirmation by immunoperoxidase studies on bone narrow sections. Am J Clin Pathol 83:681–686, 1985.PubMedGoogle Scholar
  208. 208.
    Garcia CF, Weiss LM, Warnke RA: Small noncleaved cell lymphoma: An immunophenotypic study of 18 cases and comparison with large cell lymphoma. Hum Pathol 17:454–461, 1986.PubMedGoogle Scholar
  209. 209.
    Mangan KF, Rauch AE, Bishop M, et al: Acute lymphoblastic leukemia of Burkitt’s type (L-3 ALL) lacking surface immunoglobulin and the 8; 14 translocation. Am J Clin Pathol 83:121–126, 1985.PubMedGoogle Scholar
  210. 210.
    Gluck WL, Bigner SH, Borowitz MJ, Benchman WD: Acute lymphoblastic leukemia of Burkitt’s type (L3-ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulins. Am J Clin Pathol 85:636–640, 1986.PubMedGoogle Scholar
  211. 211.
    Cooper MD: Pre-B cells: Normal and abnormal development. J Clin Immunol 1:81–89, 1981.PubMedGoogle Scholar
  212. 212.
    Mann RB, Jaffe ES, Braylan RC, Nanba K, Frank MM, Ziegler JL, Berard CW: Non-endemic Burkitt’s lymphoma: A B-cell tumor related to germinal centers. N Engl J Med 295:685, 1976.PubMedGoogle Scholar
  213. 213.
    Henle W, Henle G, Lennette ET: The Epstein-Barr virus. SCi Am 241:48–60, 1979.PubMedGoogle Scholar
  214. 214.
    Douglass EC, Magrath IT, Lee EC, Whang-Peng J: Cytogenetic studies in non-African Burkitt lymphoma. Blood 55:148–155, 1980.PubMedGoogle Scholar
  215. 215.
    Krontiris TG: The emerging genetics of human cancer. N Engl J Med 309:404, 1983.PubMedGoogle Scholar
  216. 216.
    Whittle, et al: T-cell control of Epstein-Barr virus-infected B-cells is lost during P falciparum malaria. Nature 312:449, 1984.PubMedGoogle Scholar
  217. 217.
    Popovic M, et al: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497, 1984.PubMedGoogle Scholar
  218. 218.
    Salmon S, Seligman M: B-cell neoplasia in man. Lancet 2:1230, 1974.PubMedGoogle Scholar
  219. 219.
    Wood GS, et al: Human dendritic cells and macrophages: In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. Am J Pathol 119:73, 1985.PubMedGoogle Scholar
  220. 220.
    Lane, et al: Stage-specific transforming genes of human and mouse B- and T-lymphocyte neoplasms. Cell 28:873, 1982.PubMedGoogle Scholar
  221. 221.
    Payne CM, Nagle RB, Borduin VF, Kim A: An ultrastructural evaluation of the cell organelle specificity of the uranaffin reaction in two human endocrine neoplasms. J Submicrose Cytol 15:833–841, 1983.Google Scholar
  222. 222.
    Payne CM, Nagle RB, Borduin V: An ultrastructural cytochemical stain specific for neuroendocrine neoplasms. Lab Invest 51:350–365, 1984.PubMedGoogle Scholar
  223. 223.
    Herrera GA, Crofts JL, Roberts CR: Neurosecretory granule-like structures in lymphomas. Hum Pathol 11:449–457, 1980.PubMedGoogle Scholar
  224. 224.
    Piled S, Martinelli G, Rivano MT, Biagini G, Govoni E: Neurosecretory-like granules in non-Hodgkin’s malignant lymphomas. Human Pathol 15:588–589, 1984.Google Scholar
  225. 225.
    Waldron JA, Leech JH, Glick AD, Flexner JM, Collins RD: Malignant lymphoma of peripheral T-lymphocyte origin. Cancer 40:1604–1617, 1977.PubMedGoogle Scholar
  226. 226.
    Brisbane JU, Berman LD, Neiman RS: Peripheral T-cell lymphoma: A clincopathologic study of nine cases. Am J Clin Pathol 79:285–293, 1983.PubMedGoogle Scholar
  227. 227.
    Greer JP, York JC, Cousar JB, Mitchell RT, Flexner JM, Collins RD, Stein RS: Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. J Clin Oncol 2:788–798, 1984.PubMedGoogle Scholar
  228. 228.
    Weis JW, Winter MW, Phyliky RL, Banks PM: Peripheral T-cell lymphomas: Histologic, immunohistologic, and clinical characterization. Mayo Clin Proc 6:411–426, 1986.Google Scholar
  229. 229.
    Van der Valk P, Willemze R, Meijer CJ: Peripheral T-cell lymphomas: A clinicopatho-logical and immunological study of 10 cases. Histopathol 10: 235–249, 1986.Google Scholar
  230. 230.
    Wright DH: T-cell lymphomas. Histopathol 10:321–326, 1986.Google Scholar
  231. 231.
    Haynes BF, Hensley LL, Jegasothy BU: Phenotypic characterization of skin infiltrating T cells in cutaneous T-cell lymphomas: Comparison with benign cutaneous infiltrates. Blood 60:463–473, 1982.PubMedGoogle Scholar
  232. 232.
    Todes-Taylor N, Turner R, Wood GS, Startle PT, Morhenn VB: T cell subpopulations in alopecia areola. J Am Acad Dermatol 11:216–223, 1984.PubMedGoogle Scholar
  233. 233.
    Luke RJ, Collins RD: New approaches to the classification of the lymphomata. Br J Cancer 31(suppl 2):l–28, 1975.Google Scholar
  234. 234.
    Lennert K: Malignant lymphomas other than Hodgkin’s Disease: Histology, cytology, ultrastructure, immunology. New York, Springer-Verlag 1978, pp 196–209.Google Scholar
  235. 235.
    Watanabe S, Nakajima T, Shimosato Y, Shimoyama M, Minato K: T-cell malignancies: Subclassification and interrelationship. Jpn J Clin Oncol 9(Suppl):423–442, 1979.Google Scholar
  236. 236.
    Collins RD, Waldron JA, Glock AD: Results of multiparameter studies of T-cell lymphoid neoplasms. Am J Clin Pathol 72(Suppl):699–707, 1979.PubMedGoogle Scholar
  237. 237.
    Muller-Hermelink HK, Steinmann G, Stein H, Lennert K: Malignant lymphoma of plasmatoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol 7:849–862, 1983.PubMedGoogle Scholar
  238. 238.
    Prastohofer E F, Grizzie WE, Prchal JT, Grossi CE: Plasmacytoid T-cell lymphoma associated with chronic myeloproliferative disorder. Am J Clin Pathol 9:380–387, 1985.Google Scholar
  239. 239.
    Kadin ME, Kamoun M, Lamberg J: Erythrophagocytic T λ lymphoma. N Engl J Med 304:648–653, 1981.PubMedGoogle Scholar
  240. 240.
    Shimoyama M, Mirato K, Saito H, Takenaka T, Watanabe S, Nagatani T, Naruto M: Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma. Jpn J Clin Oncol 9(Suppl): 347–356, 1979.Google Scholar
  241. 241.
    Jaffe ES: Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 2:413–426, 1984.PubMedGoogle Scholar
  242. 242.
    Lippman SM, Grogan TM, Spier CM, Koopman CF, Gall EP, Schimm DS, Durie BG: Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer, 59:936–939, 1987.PubMedGoogle Scholar
  243. 243.
    Jaffe ES, Blattner EA, Blaynew DW, et al: The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. Am J Surg Pathol 8:263–275, 1984.PubMedGoogle Scholar
  244. 244.
    Uchiyama T, Yodoi J, Sagawa K, Tatasuki K, Uchino H: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50:481–492, 1977.PubMedGoogle Scholar
  245. 245.
    Blattner WA, Kalyanaraman VS, Robert-Guroff M, et al: The human type-C retrovirus, HTLV, in blacks from the Caribbean region and relationship to adult T-cell leukemia/ lymphoma. Int J of Cancer 30:2457–264, 1982.Google Scholar
  246. 246.
    Cossman J, Jaffe ES, Risher RI: Diversity of immunologic phenotypes of T-cell lymphoma. Am J Surg Pathol 6:71, 1982.Google Scholar
  247. 247.
    Horning SJ, Weiss LM, Crabtress GS, Warnke RA: The clinical and phenotypic heterogeneity of T cell lymphoma. Blood 67:1578–1582, 1986.PubMedGoogle Scholar
  248. 248.
    Kalyanaraman VS, Sarngodharan MG, Robert-Guroff M, Miyoshi I, Blayngy D, Golde D, Gallo RC: A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571, 1982.PubMedGoogle Scholar
  249. 249.
    Weiss LM, Wood GS, Trela M, Warnke RA, Sklar J: Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 315:475–479, 1986.PubMedGoogle Scholar
  250. 250.
    Colby TV, Carrington CB: Pulmonary lymphomas: Current concepts. Hum Pathol 14: 884–887, 1983.PubMedGoogle Scholar
  251. 251.
    Kadin M: Common activated helper — T cell origin for lymphomatoid populosis, mycosis fungoides, and some types of Hodgkin’s disease. Lancet 2:864–865, 1985.PubMedGoogle Scholar
  252. 252.
    Weiss LM, Strickler JG, Dorfman RF, Horning SJ, Warnke RA, Sklar J: Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lympha-denopathy-like lymphoma. Am J Pathol 122:392–397, 1986.PubMedGoogle Scholar
  253. 253.
    Hsu SM, Jaffe ES: Leu Ml and peanut agglutinin stain the neoplastic cells of Hodgkins disease. Am J Clin Pathol 82:29–32, 1984.PubMedGoogle Scholar
  254. 254.
    Pinkus GS, Thomas P, Said JW, Leu MI: A marker for Reed-Sternberg cells in Hodgkins disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 119: 244–252, 1985.PubMedGoogle Scholar
  255. 255.
    Foon KA, Schroof RW, Gale RP: Surface markers on leukemia and lymphoma cells: Recent advances. Blood 60:1–19, 1982.PubMedGoogle Scholar
  256. 256.
    Ruiz-Arquelles G, Katzman JA, Greipp PR, Gonchoroff NJ, Garton JP, Kyle RA: Multiple myeloma: Circulating lymphocytes that express plasma cell antigens. Blood 64:352, 1984.Google Scholar
  257. 257.
    Cangaris-Cappio F, Bergui L, Tesio L, et al: Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest 76:1243–1251, 1985.Google Scholar
  258. 258.
    Durie BGM, Vela E, Baum V, et al: Establishment of two new myeloma cell lines from bilateral pleural effusions: Evidence for sequential in vivo clonal change. Blood 66:548–555, 1985.PubMedGoogle Scholar
  259. 259.
    Grogan TM, Durie BGM, Lomen C, et al: Delineation of a novel pre-B cell component in plasma cell myeloma: Immunochemical, immunophenotypic, cytologic, cell culture and kinetic features. Blood 70:932–942, 1987.PubMedGoogle Scholar
  260. 260.
    Ralfkiaer E, Wantzin GL, Mason DY, Hou-Jensen K, Stein H, Thomsen K: Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses. Am J Clin Pathol 84:610–619, 1985.PubMedGoogle Scholar
  261. 261.
    Wood GS, Abel EA, Hoppe RT, Warnke RA: Leu 8 and Leu 9 antigen phenotypes: Immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. J Amer Acad Dermatol 14:1006–1013, 1986.Google Scholar
  262. 262.
    Rowden G, Lewis MG: Langerhans cells: Involvement in the pathogeneisis of mycosis fungoides. Br J Dermatol 95:665–672, 1976.PubMedGoogle Scholar
  263. 263.
    Patterson JAK, Edelson R: Interaction of T cells with epidermis. Br J Dermatol 107:117–122, 1982.PubMedGoogle Scholar
  264. 264.
    Payne CM, Grogan TM, Lynch PJ: An ultrastructural, morphometric and immunohisto-chemical analysis of cutaneous lymphomas and benign lymphocytic infiltrates of skin: Useful criteria for diagnoses. Arch Derm 122:1139–1154, 1986.PubMedGoogle Scholar
  265. 265.
    Wieczorek R, Suhrland M, Ramsay D, Reed ML, Knowles DM: Leu Ml expression in advanced (tumor) stage mycosis fungoides. Am J Clin Pathol 86:25–32, 1986.PubMedGoogle Scholar
  266. 266.
    Kim H, et al: Composite lymphoma. Cancer 40:949–976, 1977.Google Scholar
  267. 267.
    Jaffe ES, et al: Functional markers: A new perspective on malignant lymphomas. Cancer Treat Rep 61:953–962, 1977.PubMedGoogle Scholar
  268. 268.
    Hoppe RT: Histologic variation in non-Hodgkins lymphomas: Commentary. Cancer Treat Rep 65:935–939, 1981.PubMedGoogle Scholar
  269. 269.
    Fisher RI: Natural history of malignant lymphomas with divergent histologies at staging evaluation. Cancer 47:2022–2025, 1981.PubMedGoogle Scholar
  270. 270.
    Anderson NG, Anderson NL: The human protein index. JAMA 246:2620–21, 1981.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • Thomas M. Grogan
  • Catherine M. Spier
  • Lynne C. Richter
  • Catherine S. Rangel

There are no affiliations available

Personalised recommendations